Newsletter - June 2022

HCP Social Media Insights

Featured Content

HCP Social Media Insights

HCP Social Media Insights

Via DHC →
There’s no question social media has come a long way from the early days of social networking platforms such as MySpace and Friendster. Much like the computer or the smartphone, social media is now a vital communication technology. The time is now for pharma marketers to give HCP social media a good, hard look because most of their customers are already there. The DHC Group continues to examine HCP social media behaviors in an ongoing educational research project (get up to speed). Recent survey data insights dive deeper into digital influencers, HCP social media drivers and pharma opportunities. Read a summary of these findings in this month's feature article.

Read Featured Article →

DHC Partner Insights

How Are HCPs Currently Engaging Social Media Platforms

How are HCPs Currently Engaging, Learning, and Networking on Social Media Platforms?

For this IQVIA infographic, we surveyed our industry-leading database to help us understand how HCPs are currently using social media platforms to engage with professional and educational content, as well as connect with their colleagues, patients, and communities on the latest advancements in public health, prescription drugs, medical devices/technology, and OTC treatments.

View Infographic →

Don't Make Ads Make TikToks

“Don’t make ads. Make TikToks"; but is it true for pharma?

Via Underscore →
Underscore’s Director of Programmatic & Social, Rose Sumrall examines one of the hottest new social media platforms emerging for HCP marketers. Read her take on the new opportunities for pharma brands being offered by platforms like TikTok, and garner insights from an objective summary of the pros, and cons, to look out for when thinking of integrating it into your omnichannel digital pharma marketing strategy.

Learn More →

Reach Your Audiences Where They Are

Reach Your Audiences Where they Are: Engaging HCPs on Social Media

Via MedPage Today →
The latest omni-channel platform extension gives pharma access to up to 84% of prioritized HCPs on social media with content that is specific to their specialty.

Learn More →

New findings from 2022/2023 CMI Media Group Media Vitals

Via CMI Media Group →
New findings from 2022/2023 CMI Media Group Media Vitals™ research show that HCPs are actively seeking to engage with peers and colleagues on social media. A third of respondents to CMI Media Group’s survey of healthcare professionals report consulting with peers or viewing thought leadership content on social channels at least once per month. Reach out for more insights into how HCPs use social media, or request your advanced copy of the full 2022/2023 What Prescribers Want and Need from Life Sciences Manufacturers report.

Reach Out →


OptimizeRx’s New Omnichannel Partnership Reaches up to 84% of Priority HCPs on Social Networks

Via OptimizeRx →
The latest omni-channel platform extension gives pharma access to up to 84% of prioritized HCPs on social media with content that is specific to their specialty.

Learn More →

Report Now Available: Inflation, Equity, AI & ​ Patient Choice in Healthcare​

Read our recent HCP Sentiment Series Report to learn about how healthcare professionals interact with AI-tools, how patients influence prescribing habits, and what impacts inflation is having on spending habits.

Read Report →

Listening to your patients

Listening to Your Patients: How to Capture Feedback Along the Prescription Medication Journey

Via Medallia →
To better understand how to facilitate the feedback process between patients, healthcare providers, and pharmaceutical companies, we conducted an online survey of 290 patients taking medications for several common illness. Based on insights gathered from our research, we identified three ways in which healthcare providers and pharmaceutical companies can connect with patients to solicit greater and more consistent feedback.

Read Report →

Customers Speak: Laying the Foundation for Omnichannel AI at Scale

Customers Speak: Laying the Foundation for Omnichannel AI at Scale

Via Aktana →
In this special episode of Contextual Intelligence, industry leaders from Biogen, Genentech and Novartis draw from their firsthand experience deploying AI programs to share what they’ve learned in a frank roundtable discussion from Aktana’s recent Masterclass event.

Listen to Podcast →

veeva logo

Building Privacy-Safe Health Audience Segments

Via Veeva →
With an increased focus on data privacy in social channels and growing legislative momentum, the Network Advertising Initiative (NAI) guidelines are an essential framework for digital advertising. Get answers to common questions when it comes to building and activating health audience segments safely as part of an audience targeting strategy.

Learn More →

Susan G. Komen, PatientPoint campaign aims for breast cancer outcome equity

Susan G. Komen, PatientPoint Campaign Aims for Breast Cancer Outcome Equity

Via PatientPoint →
PatientPoint announced that it will support Susan G. Komen’s Stand for H.E.R program by offering point-of-care technology resources to metropolitan areas with the largest mortality gap between Black and white women.

Learn More →

Get Involved

DHC wave logo

A DHC Summit on Customer Experience

Hosted with Genentech

Date: November 9, 2022
Location: San Francisco


Pharma Marketers Respond to Agile Operations -Tell us what you think

Add Your Voice

DHC Group is resarching Omnichannel Marketing for Pharma and we would like to include your perspective. We are asking pharmaceutical, device and biotech marketers to take 10 - 15 minutes to complete an anonymous survey on the topic of Omnichannel Marketing.

Take Survey →

DHC Content

More DHC content coming soon, stay tuned

Nikheel Kolatkar

DHC Short Takes

In this new DHC Short Take with Nikheel Kolatkar with Genentech, Mark Bard discusses innovation in clinical trials, the rapid uptake of digital health tools within patient populations and the impact on post-marketing strategy.

Watch Short Take →

Subscribe to Newsletter

Receive more DHC content like this directly in your inbox. We will respect your privacy and never sell your information. View our Privacy Policy.

* indicates required